Hyperglycemia in vivo and high glucose conditions (HG) in vitro promote TXNIP expression [21], TXNIP plays a pathological role in both type 1 and Type 2 diabetes [20] and is also involved in the pathophysiology of diabetic complications, including diabetic retinopathy [22]. Here, TXNIP is linked to Hyperglycemia.